Pfizer, Novartis lead USD 2 billion spending spree on gene therapy production Medical Dialogues Bureau28 Nov 2019 3:30 AM GMTNew Delhi: Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018,...
Roche anticipates USFDA nod for SMA drug Risdiplam by early 2020 Medical Dialogues Bureau26 Nov 2019 3:58 AM GMTRoche, whose drug Risdiplam is seen as a rival for Biogen's Spinraza and Novartis's Zolgensma gene therapy, said the FDA is due to decide by May 24....
SETBACK: Novartis Zolgensma study halted by USFDA amid safety concerns Medical Dialogues Bureau31 Oct 2019 4:15 AM GMTNovartis shares fell 1% at 0715 GMT, while other European drugmakers rose. Analysts said more information was needed to assess whether these findings...
Novartis sees gene, cell therapy reaching up to 15pc of total revenue in midterm Medical Dialogues Bureau5 Sep 2019 3:45 AM GMTZURICH: Novartis sees cell and gene therapies accounting for up to 15% of its total revenue in the midterm from a much lower level at present, a Swiss...
Roche, Spark Therapeutics $4.3 billion deal delayed again amid US, UK scrutiny Farhat Nasim10 Jun 2019 4:00 AM GMTRoche said on Monday that both companies received a request for more information from the U.S. Federal Trade Commission in connection with the FTC's...
Novartis gets USFDA nod for over Rs 13 crore gene therapy Zolgensma Farhat Nasim25 May 2019 4:30 AM GMTThe Food and Drug Administration on Friday approved the treatment, called Zolgensma, for all children under age 2 who are confirmed by a genetic test...
Novartis to buy France's CellforCure to boost cell, gene therapy Medical Dialogues Bureau24 Dec 2018 3:30 AM GMTNovartis, which already has an agreement with CellforCure to help make Kymriah, said it aims to add CellforCure's facilities to a similar factory in...
Gene therapy for rare form of blindness wins US approval Ruby Khatun Khatun21 Dec 2017 4:34 AM GMTWASHINGTON: U.S. health officials on Tuesday approved the nation's first gene therapy for an inherited disease, a treatment that improves the sight of...
Gene therapy becomes reality, but at a price tag of 1 million dollar Ruby Khatun Khatun20 Nov 2017 4:15 AM GMTLONDON: Battle lines are being drawn as the first gene therapy for an inherited condition nears the U.S. market, offering hope for people with a rare...
Britain backs GSK gene therapy for BUBBLE BOY syndrome Ruby Khatun Khatun23 Oct 2017 4:02 AM GMTGlaxoSmithKline's (GSK) gene therapy for the so-called "bubble boy" disease was approved by Britain's healthcare cost watchdog NICE, despite a price...
